Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04383535
What this trial is testing

Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia

Who this might be right for
SARS VirusSARS-CoV-2COVID-19
Hospital Italiano de Buenos Aires 333
Testing effectiveness (Phase 2)Study completedNCT04975555
What this trial is testing

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

Who this might be right for
Cytokine Release SyndromeICANSLymphoma, Non-Hodgkin+2 more
University of Alabama at Birmingham 20
Post-approval studies (Phase 4)Study completedNCT00733538
What this trial is testing

Stage I Multiple Myeloma Treatment

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire de Nice 89
Not applicableStudy completedNCT00569868
What this trial is testing

UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
MULTIPLE MYELOMA
University of Arkansas 11
Early research (Phase 1)Active Not RecruitingNCT05391750
What this trial is testing

Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Emory University 7
Not applicableNot Yet RecruitingNCT07773740
What this trial is testing

Autologous Plasma Rich in Growth Factors for Severe Dry Eye Disease

Who this might be right for
Dry Eye Disease With Severe Keratitis
Gladys Lucia Silva Linares 100
Testing effectiveness (Phase 2)Looking for participantsNCT06066346
What this trial is testing

Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 17
Early research (Phase 1)Active Not RecruitingNCT03070327
What this trial is testing

BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 20
Not applicableStudy completedNCT05622279
What this trial is testing

Percutaneous Needle Tenotomy Associated With Platelet-rich Plasma Injection Platelet-rich Plasma in the Treatment of Refractory Plantar Fasciitis: a Pilot Study of the Effect on Pain and Tolerance

Who this might be right for
Plantar Fascitis
Nantes University Hospital 19
Early research (Phase 1)UnknownNCT05698303
What this trial is testing

Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. 12
Not applicableStudy completedNCT04973488
What this trial is testing

Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionAcute Respiratory Failure+1 more
Novacescu Alexandru 38
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05669989
What this trial is testing

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

Who this might be right for
Plasma Cell Myeloma
Sanofi 70
Testing effectiveness (Phase 2)UnknownNCT02093910
What this trial is testing

Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy

Who this might be right for
Multiple Myeloma
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT07084896
What this trial is testing

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 106
Post-approval studies (Phase 4)Study completedNCT06249503
What this trial is testing

Ultrasound Guided Activated and Non Activated Platelet Rich Plasma Injection Versus Hydro Dissection by Steroids.

Who this might be right for
Carpal Tunnel SyndromeCompare Steroids Versus PRP in Dissection of Median Nerve by Ultrasound
Ain Shams University 90
Large-scale testing (Phase 3)Ended earlyNCT03221842
What this trial is testing

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
CSL Behring 63
Testing effectiveness (Phase 2)Looking for participantsNCT05583617
What this trial is testing

A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hoffmann-La Roche 200
Post-approval studies (Phase 4)UnknownNCT04989140
What this trial is testing

Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide

Who this might be right for
Multiple Myeloma
Peking Union Medical College Hospital 60
Not applicableUnknownNCT06370650
What this trial is testing

Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological Study

Who this might be right for
Management of Stable Vitiligo
Sohag University 30
Early research (Phase 1)UnknownNCT05740891
What this trial is testing

AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Zhejiang University 50
Next Page